SOPHiA GENETICS SA (SOPH) Misses Q2 EPS by 11c, provides guidance

SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q2 EPS of ($0.33), $0.11 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $18.3 million versus the consensus estimate of $17.49 million.

GUIDANCE:

SOPHiA GENETICS SA sees FY2025 revenue of $72-76 million, versus the consensus of $74.2 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance